Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Kenneth J. Sufka"'
Publikováno v:
Cannabis and Cannabinoid Research. 7:804-813
Autor:
Hayley M. Schrock, Thomas E. Prisinzano, Kevin B. Freeman, Kenneth J. Sufka, Bruce E. Blough, C. Austin Zamarripa, Tanya Pareek
Publikováno v:
Psychopharmacology (Berl)
RATIONALE: Triazole 1.1 is a novel kappa-opioid receptor (KOR) agonist reported to produce antinociception without KOR-typical adverse effects. When combined with the mu-opioid receptor (MOR) agonist, oxycodone, triazole 1.1 blocks oxycodone-induced
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103362 (2014)
Most pre-clinical analgesic efficacy assays still involve nociceptive testing in rodents. This is despite concerns as to the relevance of these tests for evaluating the pain-preventative properties of drugs. More appropriate methods would target pain
Externí odkaz:
https://doaj.org/article/bc891cae1b00457dabe00d12e11e012c
Publikováno v:
Med Cannabis Cannabinoids
Objective: This research examined whether a cannabidiol (CBD)-opioid pharmacotherapy could attenuate cisplatin-induced tactile allodynia. Methods: Mice (C57BL/6) were given 6 doses of 2.3 mg/kg cisplatin intraperitoneally (IP) on alternating days to
Publikováno v:
Planta Medica. 84:221-224
This study sought to determine whether the cannabis constituent cannabidiol attenuates the development of morphine reward in the conditioned place preference paradigm. Separate groups of mice received either saline or morphine in combination with one
Autor:
Jessica M. Carpenter, Jonathan R. Black, Hannah M. Harris, Kenneth J. Sufka, Todd A. Smitherman
Publikováno v:
Journal of Neuroscience Methods. 284:63-70
Background Rodent models typically use a single nitroglycerin injection to induce migraine, yet migraine in clinical populations presents as recurrent episodes. Further, these models quantify behavioral endpoints that do not align with the clinical f
Autor:
Hina N. Qureshi, Kenneth J. Sufka, Jussara M. do Carmo, Coco N. Kapanda, Hunter W. McLendon, Fernanda S. da Silva, John E. Hall, S. Stevens Negus, Jennifer E. Naylor, E. Andrew Townsend, Kevin B. Freeman, Shelley R. Edwards, Christopher R. McCurdy
Publikováno v:
Psychopharmacology. 234:2597-2605
Strategies to reduce the misuse of mu opioid agonists are critically needed. Previous work has shown that kappa opioid agonists can diminish the abuse-related effects and augment the antinociceptive effects of mu agonists. However, use of traditional
Autor:
Mahmoud A. ElSohly, Hannah M. Harris, Amira S. Wanas, Sylvia Caldwell, Kenneth J. Sufka, Mohamed M. Radwan, Margaret A Rousseau
Publikováno v:
Cannabis Cannabinoid Res
Introduction: Cannabis sativa has been used for centuries in treating pain. However, the analgesic role of many of its constituents including terpenes is unknown. This research examined the contributions of terpenes (volatile oil) and cannabinoids in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b1eef52695ecfe1385d9a436957d71
https://europepmc.org/articles/PMC6757239/
https://europepmc.org/articles/PMC6757239/
Autor:
Ikhlas A. Khan, Helaina K. Craig, Jessica M. Carpenter, Catherine A. Criddle, Kenneth J. Sufka, Zulfiqar Ali, Zhihao Zhang
Publikováno v:
Fitoterapia. 109:87-90
This study sought to compare the effects of Mitragyna speciosa (Korth.) Havil. extract, alkaloids fraction, and mitragynine, a μ-opioid receptor agonist, to that of morphine and oxycodone in a test of thermal nociception. In Experiment 1, male Sprag